|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and Due From Banks: | ||||||||||||||||||||
| Interest-Earning | ||||||||||||||||||||
| Noninterest-Earning | ||||||||||||||||||||
| Total Cash and Due From Banks | ||||||||||||||||||||
| Securities: | ||||||||||||||||||||
| Available-for-Sale Debt Securities, at Fair Value | ||||||||||||||||||||
| Equity Securities, at Fair Value | ||||||||||||||||||||
| Total Securities | ||||||||||||||||||||
| Loans Held for Sale | ||||||||||||||||||||
| Loans, Net of Allowance for Credit Losses of $10,451 and $10,116 at June 30, 2026 and December 31, 2025, Respectively | ||||||||||||||||||||
| Premises and Equipment, Net | ||||||||||||||||||||
| Bank-Owned Life Insurance | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible Assets, Net | ||||||||||||||||||||
| Accrued Interest Receivable and Other Assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-Bearing Demand Accounts | ||||||||||||||||||||
| Interest-Bearing Demand Accounts | ||||||||||||||||||||
| Money Market Accounts | ||||||||||||||||||||
| Savings Accounts | ||||||||||||||||||||
| Time Deposits | ||||||||||||||||||||
| Brokered Deposits | ||||||||||||||||||||
| Total Deposits | ||||||||||||||||||||
| Short-Term Borrowings | ||||||||||||||||||||
| Other Borrowings | ||||||||||||||||||||
| Accrued Interest Payable and Other Liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Preferred Stock, No Par Value; 5,000,000 Shares Authorized | ||||||||||||||||||||
| Common Stock, $0.4167 Par Value; 35,000,000 Shares Authorized, 5,877,305 Shares Issued and 5,080,438 Shares Outstanding at June 30, 2026, with 5,835,325 and 5,036,509 Shares Issued and Outstanding at December 31, 2025. | ||||||||||||||||||||
| Capital Surplus | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Treasury Stock, at Cost (796,867 and 798,816 Shares at June 30, 2026 and December 31, 2025, Respectively) | ||||||||||||||||||||
| Accumulated Other Comprehensive Loss | ||||||||||||||||||||
| TOTAL STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
Loading...
